Financial Data and Key Metrics Changes - Total revenues for Q2 2026 were $12.7 million, down 3% from the prior year quarter, but would have been $13.4 million, up 5%, if a $1.1 million licensing deal for the Toxic Avenger was recognized [5][14] - Operating margins improved by 7% from the prior year quarter to 58% [5] - Net loss for the quarter was $5.5 million, compared to a net loss of $1.2 million in the prior year quarter [15] - Adjusted EBITDA was negative $3.7 million, down from positive $0.5 million in the prior year quarter [15] - Cash and cash equivalents were $2.3 million as of September 30, with $5.9 million available on a $12.5 million working capital facility [15][16] Business Line Data and Key Metrics Changes - The performance of the Toxic Avenger Unrated was below expectations at the box office, but it is expected to be profitable with an IRR of 40% due to strong ancillary distribution [6][9] - The company continues to focus on controlling costs and leveraging efficiencies from Cineverse Services India to manage SG&A spending [6] - The upcoming releases, Silent Night Deadly Night and Return to Silent Hill, are projected to follow a similar low-cost investment strategy [9] Market Data and Key Metrics Changes - Total streaming viewers reached 143.8 million, up 47% year over year, with total minutes streamed at 3.4 billion, up 45% [18] - SVOD subscribers grew to 1.39 million, a 6% increase year over year [18] - The Cineverse branded channel grew more than 6,400% in viewership since its relaunch in January [19] Company Strategy and Development Direction - The company is focusing on a fan-centric, IP-based film strategy, avoiding mixed-genre films in the future [31] - The Match Point technology sales pipeline is expanding, with dozens of potential partners actively evaluating the technology [12][23] - The MicroCo joint venture aims to become a leader in the micro-drama market, which is expected to represent a significant portion of streaming viewing time [24][25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence that investments made in sales, marketing, and technology will yield strong results in the remainder of the fiscal year and beyond [15][17] - The advertising environment is mixed, but there is optimism for growth as political spending ramps up in Q4 [20][21] - The company believes it is well-positioned for future growth with multiple engines of growth supported by technology and a growing audience [26] Other Important Information - The content library is now valued at $45 million, significantly above the $3.2 million book value [12][16] - The company is actively seeking strategic partnerships and acquisitions to enhance its technology offerings [24][40] Q&A Session Summary Question: Impact of Toxic Avenger's performance on future slate - Management believes the performance validated their theatrical releasing strategy and will influence future film selections to avoid mixed-genre movies [30][31] Question: Timing of monetization for Match Point - Management indicated that while the sales cycle is longer, there is strong interest from studios, and they expect significant revenue contributions in the next 12-24 months [32][33]

Group 1 - The focus has shifted towards offshore drilling, supply industry, and shipping, including tankers, containers, and dry bulk [1] - The fuel cell industry is being monitored as it is still in its early stages of development [1] Group 2 - The individual has extensive experience in auditing and trading, having navigated significant market events such as the dotcom bubble and the subprime crisis [2] - The research provided aims to maintain high quality despite language barriers [2]

Core Insights - Cineverse has partnered with Iconic Events Releasing for the theatrical distribution of "The Toxic Avenger," set for an unrated wide release on August 29, 2025, following the success of "Terrifier 2" and "Terrifier 3," which grossed over $65 million at the domestic box office [1][2] Group 1: Film Details - "The Toxic Avenger" is a comedic horror film directed by Macon Blair, featuring Peter Dinklage and receiving critical acclaim with a 92% score on Rotten Tomatoes [2][3] - The film is a modern reimagining of the classic franchise, focusing on themes of corporate greed and social injustice, while maintaining the original's irreverent humor and practical effects [2][3] Group 2: Company Background - Cineverse is a next-generation entertainment studio that distributes content across various platforms, including theatrical, digital, and physical formats, and has recently seen success with "Terrifier 3" [4][7] - Bloody Disgusting, the horror division of Cineverse, serves horror fans through various media, including a leading website, podcasts, and a streaming service [5] Group 3: Distribution Partnership - Iconic Events Releasing has been selected as the distribution partner for "The Toxic Avenger," with a focus on honoring the franchise's legacy while appealing to a new generation of fans [2][8] - The partnership aims to deliver a unique cinematic experience, leveraging the success of previous films in the genre [2][8]